![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
|
Contact: Bonnie Kourvelas
bonnie.kourvelas@stjude.org
901-495-4815
St. Jude Children's Research Hospital
Caption: This figure shows where gefinitib first comes into contact with the transporter ABCG2 in the cells lining the intestinal lumen (enterocytes).
Credit: St. Jude Children's Research Hospital
Usage Restrictions: None
Related news release: Cancer drug side effect caused by cell 'pump' problem
|